Durable response to nivolumab rechallenge in a patient with metastatic clear cell renal cell carcinoma

Introduction While immune checkpoint inhibitors represent the mainstream treatment for metastatic renal cell carcinoma, a standardized approach following immune checkpoint inhibitors remains unclear. We report a case of metastatic renal cell carcinoma treated with nivolumab rechallenge. Case present...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Motohiro Fujiwara, Wataru Shimada, Minato Yokoyama, Anri Koyanagi, Hiroshi Shintaku, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Wiley 2024-07-01
Ráidu:	IJU Case Reports
Fáttát:	clear cell renal cell carcinoma immune checkpoint inhibitors nivolumab nivolumab rechallenge
Liŋkkat:	https://doi.org/10.1002/iju5.12727
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!